{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_181808.3:c.6056A>G",
          "cDNA Change": {
            "transcript": "NM_181808.3",
            "ref": "A",
            "alt": "G",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "c.6056A>G (p.G2019S)"
        }
      ]
    },
    {
      "Gene": "PARK2",
      "variants": [
        {
          "HGVS": "NM_004564.4:c.139C>G",
          "cDNA Change": {
            "transcript": "NM_004564.4",
            "ref": "C",
            "alt": "G",
            "position": "139"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "H",
            "position": "47"
          },
          "Description in input context": "c.139C>G (p.R47H)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005222"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transfected with wild-type or mutant LRRK2 constructs."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_181808.3:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "p.G2019S increased LRRK2 kinase activity by 150% compared to wild-type."
        },
        {
          "Variant": "NM_004564.4:c.139C>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "p.R47H reduced PARK2 ubiquitin ligase activity by 70%."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were conducted for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 construct used as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector used as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two-tailed Student's t-test with p < 0.05 as significant."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within 20% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity exceeding 50% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Postmortem brain tissue",
        "Description": "Lewy body pathology was analyzed in postmortem brain tissue from Parkinson's patients."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_181808.3:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "p.G2019S correlated with increased α-synuclein aggregation in Lewy bodies."
        },
        {
          "Variant": "NM_004564.4:c.139C>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "p.R47H correlated with reduced ubiquitination of parkin substrates."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "No",
        "Description": "No biological replicates mentioned."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Slides were stained in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "No positive control described."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "No negative control described."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "No statistical analysis reported."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal α-synuclein distribution with no Lewy bodies.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Abnormal α-synuclein aggregation in Lewy bodies.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}